EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diagnosis and risk factors in pancreatogenic diabetes

Ravi Kumar Sharma, Alpa Singh, Saurabh Dawra

Advances in Clinical Chemistry · 2026

DOI: 10.1016/bs.acc.2025.10.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2026. Verfasst von Ravi Kumar Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India. Electronic address: ravisharma1j@gmail.com. Hauptthemen laut MEDLINE: Diabetes Mellitus. Die Arbeit nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatogenic diabetes, i.e. Type 3c Diabetes Mellitus (T3c), is a distinct clinical entity primarily caused by underlying pancreatic disorders. These include acute, chronic, or recurrent pancreatitis, traumatic pancreatitis, pancreatic surgery, cystic fibrosis and pancreatic cancer. Although T3c accounts for approximately 10-15 % of all diabetes, its true burden within the spectrum of pancreatic diseases has been explored in only a limited number of studies. T3c is characterised by both endocrine and exocrine pancreatic insufficiency, and is notable for significant glucose fluctuations resulting from pancreatic tissue loss. It is often misdiagnosed as type 2 diabetes mellitus (T2), making it one of the least investigated and most overlooked forms of diabetes in routine clinical practice. This diagnostic gap frequently leads to ineffective treatment strategies and increased morbidity. Accurate diagnosis hinges on identifying the hallmark features of exocrine pancreatic insufficiency (EPI), which is common in T3c but rarely seen in T2. Two key diagnostic tests include fecal pancreatic elastase and fecal fat quantification. Fat excretion> 7 g/day strongly suggests steatorrhea and significant malabsorption. Given the clinical similarities between T3c and T2, improving diagnostic accuracy is crucial. Early recognition of distinguishing features allows for appropriate medical management and tailored treatment plans that address both endocrine and exocrine dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusHumansRisk FactorsExocrine Pancreatic InsufficiencyDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

Diagnosis and risk factorsPancreatogenic DiabetesT1DMT2DMT3cDM

Autor:innen und Institutionen

  • University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India. Electronic address: ravisharma1j@gmail.com.
  • University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India.
  • Department of Gastroenterology, Command Hospital, Udhampur, Jammu and Kashmir, India.

Zitieren

APA

Sharma, R. K., Singh, A., & Dawra, S. (2026). Diagnosis and risk factors in pancreatogenic diabetes. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2025.10.003

Vancouver

Sharma RK, Singh A, Dawra S. Diagnosis and risk factors in pancreatogenic diabetes. Advances in Clinical Chemistry. 2026. doi:10.1016/bs.acc.2025.10.003

BibTeX
@article{Sharma2026,
  author = {Sharma, Ravi Kumar and Singh, Alpa and Dawra, Saurabh},
  title = {Diagnosis and risk factors in pancreatogenic diabetes},
  journal = {Advances in Clinical Chemistry},
  year = {2026},
  doi = {10.1016/bs.acc.2025.10.003}
}
Kostenlos starten →